Endocrinology, Vol 117, 2170-2175, Copyright © 1985 by Endocrine Society

ARTICLES

Histidyl-proline-diketopiperazine (cyclo-his-pro) inhibits the suckling- and domperidone-induced transformation of prolactin in the lactating rat

SW Shyr and CE Grosvenor

The histidyl-proline-diketopiperazine (cyclo-his-pro) metabolite of TRH inhibited the transformation of prereleasable PRL within the anterior pituitary and as a consequence, the normal rise in plasma PRL levels when injected before suckling. The dose (400 ng) was administered five times at 1-min intervals. PRL suppression was similar to that resulting from dopamine injected at the same rate. Combined injections of cyclo- his-pro and dopamine, each at the 400 ng/min for 5 min rate, provoked a greater inhibition of PRL than did either alone. Neither cyclo-his-pro nor dopamine inhibited the suckling-induced release of PRL in rats whose PRL had previously been transformed by a short (10-min) period of suckling. The stimulatory effects of iv administered domperidone (0.005 or 0.01 mg/rat) and haloperidol (0.2 mg/rat) upon PRL transformation and release in the lactating rat were substantially reduced by cyclo- his-pro in a dose-related fashion over a range of doses from 200-800 ng/min for 5 min. These results demonstrate that cyclo-his-pro inhibits PRL secretion in the lactating rat after suckling, primarily through inhibition of the transformation phase, and that the inhibitory mechanism may involve an interaction with dopamine.

This article has been cited by other articles:

				L.J. Jara, C. Prasad, and L.R. Espinoza Elevated serum levels of cyclo (His-Pro), an endogenous inhibitor of pituitary prolactin secretion, in systemic lupus erythematosus patients Lupus, January 1, 1997; 6(3): 258 - 260. [Abstract] [PDF]